According to a recent LinkedIn post from Talkdesk, the company is planning a presence at HIMSS 2026 focused on its Talkdesk CXA healthcare offering and executive engagement. The post highlights a partnership with consultant Juanita Coley to conduct 30 private executive sessions aimed at aligning technology investments such as CXA with capacity strategy and automation needs.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post also notes that Coley is expected to present on workforce mistakes that can undermine digital transformation, positioning the sessions as educational for healthcare leaders. This emphasis on advisory-style interaction suggests Talkdesk is targeting higher-value, strategic buyers in healthcare, potentially supporting larger deal sizes and stickier platform adoption.
Talkdesk’s messaging around industry-trained AI agents and automation to enhance patient access points to continued investment in verticalized AI capabilities. For investors, this focus may indicate that the company is prioritizing healthcare as a key growth vertical within the CCaaS and CX automation markets, where specialized compliance and workflow requirements can create barriers to entry for competitors.
The planned demos, speaking sessions, and partner presentations at the event suggest an effort to deepen ecosystem relationships and showcase product maturity at scale. If the HIMSS 2026 activities translate into new enterprise logos or expanded deployments, they could enhance Talkdesk’s recurring revenue base and reinforce its positioning in AI-driven healthcare engagement.